RE:RE:TIGIT class of checkpoint inhibitors fails with Keytruda July 04, 2024 - Roche/Genentech anti-TIGIT fails SKYSCRAPER - 06 study in NSCLC showing reduced efficacy in both PFS and OS compared to Keytruda + chemotherapy.
https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-inc?postid=36117846